Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Buy
63
CDRE Quote, Financials, Valuation and Earnings
Last price:
$35.38
Seasonality move
:
12.96%
Day range:
$34.69 - $35.48
52-week range:
$27.07 - $40.28
Dividend yield:
1.03%
P/E ratio:
37.15x
P/S ratio:
2.58x
P/B ratio:
4.52x
Volume:
345.1K
Avg. volume:
330K
1-year change:
18.03%
Market cap:
$1.4B
Revenue:
$567.6M
EPS (TTM):
$0.95
Earnings Data
Next earnings date for CDRE
Aug 12
2025
Most recent earnings per share
$0.23
Beat by $0.07
(May 6/2025)
Consensus Estimate
$0.16
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
CDRE Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/12/2025 | Q2 | $154.9M | -- | -- | $0.30 | -- |
| 05/06/2025 | Q1 | $121.5M | $130.1M | $0.23 | $0.16 | $0.07 |
| 03/11/2025 | Q4 | $170.9M | $176M | $0.32 | $0.51 | -$0.19 |
| 11/06/2024 | Q3 | $126.3M | $109.4M | $0.09 | $0.10 | -$0.01 |
| 08/09/2024 | Q2 | $142.1M | $144.3M | $0.31 | $0.29 | $0.02 |
| 05/07/2024 | Q1 | $128M | $137.9M | $0.18 | $0.26 | -$0.08 |
| 03/05/2024 | Q4 | $121.8M | $124.6M | $0.25 | $0.21 | $0.04 |
| 11/08/2023 | Q3 | $118.8M | $125.1M | $0.29 | $0.22 | $0.07 |
| 08/08/2023 | Q2 | $112.5M | $121.1M | $0.29 | $0.15 | $0.14 |
| 05/09/2023 | Q1 | $112.7M | $111.7M | $0.19 | $0.13 | $0.06 |
| 03/15/2023 | Q4 | -- | $123.6M | $0.17 | -- | -- |
| 11/10/2022 | Q3 | -- | $111.6M | $0.13 | -- | -- |
| 08/11/2022 | Q2 | -- | $118.2M | $0.12 | -- | -- |
| 05/12/2022 | Q1 | -- | $104.4M | -$0.30 | -- | -- |
| 03/10/2022 | Q4 | -- | $103.5M | $0.13 | -- | -- |
| 12/02/2021 | Q3 | -- | $98.7M | -$0.15 | -- | -- |
| 06/30/2021 | Q2 | -- | $114.6M | $0.20 | -- | -- |
| 03/31/2021 | Q1 | -- | $110.5M | $0.21 | -- | -- |
| 12/31/2020 | Q4 | -- | $107.6M | $0.47 | -- | -- |
| 09/30/2020 | Q3 | -- | $105.7M | $0.19 | -- | -- |
| 06/30/2020 | Q2 | -- | $93.3M | $0.36 | -- | -- |
| 03/31/2020 | Q1 | -- | $97.9M | $0.12 | -- | -- |
Cadre Holdings Earnings Questions
-
How Much did Cadre Holdings Generate in Revenue Last Quarter?
Cadre Holdings reported $130.1M worth of top line sales in its most recent quarter.
-
Did Cadre Holdings Beat Earnings Last Quarter?
Cadre Holdings announced earnings per share of $0.23 which represents a beat of analyst forecast a $0.16 per share.
-
Is Cadre Holdings Profitable?
Cadre Holdings reported $56.1M that represents $1.37 per share over the last quarter.
-
What is the Analyst Consensus for Cadre Holdings EPS Next Year?
Cadre Holdings's earnings are forecast to grow from $0.90 per share to $1.27 per share next year representing an increase of 50%.
-
When is Cadre Holdings's Earnings Date?
Cadre Holdings's next earnings date is August 12, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
81
SMLR alert for May 19
Semler Scientific [SMLR] is up 5.85% over the past day.
Sell
25
GLOB alert for May 19
Globant SA [GLOB] is up 4.02% over the past day.
Buy
94
HIMS alert for May 19
Hims & Hers Health [HIMS] is down 3.57% over the past day.
